CTRI/2014/01/004271已完成未知
An open label and single dose pharmacokinetic study of Mangiferin present in the polyherbal formulation of Salacia oblonga, Salacia roxburghii, Garcinia indica and Lagestroemia parviflora in healthy, adult, male, human subjects under fasting conditions
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Ba/be
入排标准
入选标准
- •Healthy male volunteers of 18 to 45 yrs (both years inclusive) and
- •body weight > 50 kg.
- •Willing to give informed written consent and comply with the study requirements.
- •Subject should be able to communicate effectively.
- •Non-smokers or individuals who smoke less than 5 cigarettes per day
- •Teetotalers or individuals who drink less than 60 ml of high-alcohol-content
- •liquor or 120 ml of low-alcohol-content liquor
- •Body Mass Index (BMI) between 18.50 and 24.99 Kg/m2
- •Healthy individuals as evaluated by personal history,medical history and general clinical examination.
- •Vital parameters - BP should be within the range of 100 â?? 139 mmHg systolic and 60 â?? 89 mmHg diastolic. Pulse rate should be within the range of 60 â?? 100 / min.
- •Oral temperature between 97.8Ë? F and 99.0 Ë? F.
- •Respiratory rate should be within the range of 14-18/min.
- •Normal biochemical, hematological and urinary parameters.
- •Normal Chest X - ray PA view & ECG in 12 leads.
- •Negative for HIV 1 & 2, Hepatitis B, Hepatitis C and Syphilis tests.
- •Negative urine test for drugs of abuse for morphine, barbiturates,benzodiazepines, amphetamine, THC & cocaine
- •(to be performed on the day of check in).
- •Negative alcohol breath analysis (to be performed on the day of check in).
排除标准
- •Subjects incapable of understanding the informed consent.
- •History of any major surgical procedure in the past 3 months.
- •History of diabetes mellitus, tuberculosis and systemic hypertension.
- •History suggestive of cardiac, gastrointestinal, respiratory, hepatic, renal, endocrine, neurological, metabolic, psychiatric or hematological systems, judged to be clinically significant.
- •History of dysphagia.
- •History of any medical disorder that is of significance in the investigatorâ??s opinion.
- •Present or past history of drug abuse.
- •History of hypersensitivity to study formulation.
- •History of allergy to vegetables and / or food substances and / or any other manifestations suggestive of hypersensitivity reactions.
研究者
相似试验
尚未招募
不适用
Bio availability study of Berberine in Manasamitra Vatakam: An ayurvedic herbomineral formulatioCTRI/2020/02/023267SRM Institute of Science and Technology
进行中(未招募)
不适用
An open label, single dose, pharmacokinetic study of oromucosal midazolam administered to children from 3 months to less than 18 years undergoing routine elective surgery - Midazolam PKIn the context of the trial, the IMP is to be used as anaesthetic premedication in children undergoing elective routine surgery.(The medical condition for marketing is acute seizures in children aged 3 months - <18 years.)MedDRA version: 9.1Level: LLTClassification code 10058073Term: Anaesthetic premedicationEUCTR2009-012808-11-DETherakind Limited75
进行中(未招募)
不适用
A single dose study of BeneFIX (nonacog alfa, recombinant factor IX) in male Chinese subjects with haemophilia B.EUCTR2015-003027-61-Outside-EU/EEAPfizer Inc.12
招募中
不适用
Single dose open-label comparative pharmacokinetic study to assess the pharmacokinetic characteristics of Irbesartan and Atorvastatin between Irbesartan/Atorvastatin combination tablet and coadministration of Irbesartan and Atorvastatin tablets in healthy male subjectsKCT0000263Hanmi Pharm52
进行中(未招募)
不适用
Study of PF-05208756, Moroctocog Alfa (AF-CC), Xyntha For Male Chinese Subjects With Hemophilia AHemophilia AEUCTR2015-003685-88-Outside-EU/EEAPfizer Inc.13
